Polpharma Biologics Secures FDA and EMA Review for PB016
ROTKREUZ, Switzerland, July 31, 2026 Polpharma Biologics International AG announced that the U.S. Food and Drug Administration (FDA) and...
Biopharmaceuticals
Advertisement
Biohaven and Yale Secure Major Win in MODA Technology Dispute
NEW HAVEN, Conn., July 27, 2026 Biohaven Ltd. and Yale University have secured a significant legal victory after a...
argenx SE Expands Immunology Pipeline with Forte Biosciences Deal
Amsterdam, the Netherlands and Dallas, Texas – July 27, 2026 argenx has entered into a definitive agreement to acquire...
HCW Biologics Reaches FDA Pre-IND Milestone for HCW11-018b
MIRAMAR, Fla., July 23, 2026 HCW Biologics Inc. announced a significant advancement in the development of its proprietary tetravalent...
Innovent, Spero Sign $1.1B IBI355 Global Licensing Deal
SAN FRANCISCO, Calif., CAMBRIDGE, Mass., & SUZHOU, China, July 14, 2026 Innovent Biologics and Spero Therapeutics have entered into...
Advertisements
BioMarin FDA Accepts VOXZOGO sNDA for Full Approval
SAN RAFAEL, Calif., July 13, 2026 BioMarin Pharmaceutical Inc. has reached a significant regulatory milestone after the U.S. Food...
AstraZeneca Reports Wainua Phase III ATTR-CM Trial Results
CAMBRIDGE, United Kingdom, July 9, 2026 AstraZeneca and Ionis Pharmaceuticals have announced results from the Phase III CARDIO-TTRansform trial...
Ipsen Reports Positive Phase III Dysport Migraine Results
PARIS, France, July 9, 2026 Ipsen has announced positive topline Phase III results from its BEOND clinical development program,...
Immunome NDA for Varegacestat Accepted by FDA for DTs
BOTHELL, Wash., July 8, 2026 Immunome, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...
Biocytogen Partners Whitehawk on BsADC Cancer Therapies
BOSTON and MORRISTOWN, N.J., July 7, 2026 Biocytogen and Whitehawk Therapeutics have announced a global strategic collaboration to accelerate...
Advertisement
